scholarly journals Neutrophil Gelatinase-Associated Lipocalin Attenuates Ischemia/Reperfusion Injury in an In Vitro Model via Autophagy Activation

2018 ◽  
Vol 24 ◽  
pp. 479-485 ◽  
Author(s):  
Cai Yan ◽  
Tang Yuanjie ◽  
Xu Zhengqun ◽  
Chen Jiayan ◽  
Li Kongdan
2011 ◽  
Vol 165 (2) ◽  
pp. 281-282
Author(s):  
B.J. DuBray ◽  
K.D. Conzen ◽  
G.A. Upadhya ◽  
P. Balachandran ◽  
J. Jia ◽  
...  

Surgery ◽  
2012 ◽  
Vol 152 (2) ◽  
pp. 247-253
Author(s):  
Bernard J. DuBray ◽  
Kendra D. Conzen ◽  
Gundumi A. Upadhya ◽  
Parvathi Balachandran ◽  
Jianluo Jia ◽  
...  

2021 ◽  
Vol 22 (2) ◽  
pp. 510
Author(s):  
Vitale Miceli ◽  
Alessandro Bertani ◽  
Cinzia Maria Chinnici ◽  
Matteo Bulati ◽  
Mariangela Pampalone ◽  
...  

The clinical results of lung transplantation (LTx) are still less favorable than other solid organ transplants in both the early and long term. The fragility of the lungs limits the procurement rate and can favor the occurrence of ischemia-reperfusion injury (IRI). Ex vivo lung perfusion (EVLP) with Steen SolutionTM (SS) aims to address problems, and the implementation of EVLP to alleviate the activation of IRI-mediated processes has been achieved using mesenchymal stromal/stem cell (MSC)-based treatments. In this study, we investigated the paracrine effects of human amnion-derived MSCs (hAMSCs) in an in vitro model of lung IRI that includes cold ischemia and normothermic EVLP. We found that SS enriched by a hAMSC-conditioned medium (hAMSC-CM) preserved the viability and delayed the apoptosis of alveolar epithelial cells (A549) through the downregulation of inflammatory factors and the upregulation of antiapoptotic factors. These effects were more evident using the CM of 3D hAMSC cultures, which contained an increased amount of immunosuppressive and growth factors compared to both 2D cultures and encapsulated-hAMSCs. To conclude, we demonstrated an in vitro model of lung IRI and provided evidence that a hAMSC-CM attenuated IRI effects by improving the efficacy of EVLP, leading to strategies for a potential implementation of this technique.


2010 ◽  
Vol 159 (1) ◽  
pp. 451-455 ◽  
Author(s):  
Peter W. Henderson ◽  
Sunil P. Singh ◽  
Daniel Belkin ◽  
Vamsi Nagineni ◽  
Andrew L. Weinstein ◽  
...  

2012 ◽  
Vol 31 (2) ◽  
pp. 437-446 ◽  
Author(s):  
KATALIN MÓDIS ◽  
DOMOKOS GERŐ ◽  
RITA STANGL ◽  
OLIVÉR ROSERO ◽  
ATTILA SZIJÁRTÓ ◽  
...  

PLoS ONE ◽  
2014 ◽  
Vol 9 (2) ◽  
pp. e89497 ◽  
Author(s):  
Gaetano La Manna ◽  
Giulia Ghinatti ◽  
Pier Luigi Tazzari ◽  
Francesco Alviano ◽  
Francesca Ricci ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-13
Author(s):  
Ji-ling Lv ◽  
Li-na Shi ◽  
Cong-ying Zhai ◽  
Ge-jin Wang ◽  
Yan Qu

Bcl-2-associated athanogene 1 (Bag-1) is a multifunctional and antiapoptotic protein that binds to the antiapoptosis regulator Bcl-2 and promotes cell survival. To investigate the protective function of Bag-1, we examined the effects of Bag-1L, one isoform of Bag-1, in an in vitro cell culture model of lung ischemia-reperfusion injury (LIRI) generated by treatment of A549 cells with hypoxia/reoxygenation. Overexpression of full-length Bag-1L increased the viability of A549 cells and reduced cell apoptosis in response to 6 h of hypoxia/reoxygenation treatment. Furthermore, Bag-1L overexpression enhanced the heat shock protein 70 (HSP70) and Bcl-2 protein levels, increased the phosphorylation of AKT, decreased Bax and cleaved caspase-3 levels, and was able to overcome cell cycle arrest. These effects were not observed in A549 cells overexpressing a truncated form of Bag-1L lacking the “Bag domain,” denoted Bag-1L△C. The “Bag domain” is the C-terminal 47 amino acids. Taken together, the results of this study suggest that Bag-1L overexpression can protect against oxidative stress and apoptosis in an in vitro LIRI model, with a dependence on the Bag domain.


Sign in / Sign up

Export Citation Format

Share Document